News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Delgocitinib ointment safely reduces symptoms in paediatric atopic dermatitis
31 Oct 2025
byStephen Padilla
Treatment with delgocitinib ointment, a topical Janus kinase (JAK) inhibitor, for paediatric atopic dermatitis (AD) is effective and well tolerated when applied for up to 56 weeks, according to a phase III trial and a subsequent open-label, long-term study in Japan.








